Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating women
with locally advanced or metastatic breast cancer.